Bluelinx Holdings' Q2 sales rise 2% but miss estimates

Reuters
07-30
Bluelinx Holdings' <a href="https://laohu8.com/S/QTWO">Q2</a> sales rise 2% but miss estimates

Overview

  • Bluelinx Q2 sales rise 2% yr/yr but miss analyst expectations

  • Adjusted net income and EBITDA miss analyst estimates, per LSEG data

  • Co announces new $50 mln share repurchase authorization

Outlook

  • Bluelinx expects Q3 specialty product gross margin between 17% and 18%

  • Bluelinx sees Q3 structural product gross margin between 8% and 9%

Result Drivers

  • SPECIALTY PRODUCTS - Sales increased due to higher volumes across several categories, offset by price deflation

  • STRUCTURAL PRODUCTS - Sales growth driven by increased lumber prices and volumes, despite panel price declines

  • MARGIN PRESSURE - Specialty product margins declined due to competitive pricing environment, while structural margins benefited from lumber price increases

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Sales

Miss

$780 mln

$782 mln (4 Analysts)

Q2 Adjusted Net Income

Miss

$5.60 mln

$7.64 mln (4 Analysts)

Q2 Net Income

$4.30 mln

Q2 Adjusted EBITDA

Miss

$26.80 mln

$27 mln (4 Analysts)

Q2 Free Cash Flow

-$36 mln

Q2 Gross Profit

$120 mln

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the construction supplies & fixtures peer group is "buy"

  • Wall Street's median 12-month price target for Bluelinx Holdings Inc is $87.50, about 10.6% above its July 28 closing price of $78.25

  • The stock recently traded at 20 times the next 12-month earnings vs. a P/E of 16 three months ago

Press Release: ID:nBwby24zta

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10